Evidera
Neda Klenska is an experienced project manager currently serving at Evidera, leading project-level communications between sponsors and the organization while ensuring compliance with escalation protocols. Previously, Neda held the role of program manager at GemSeek, where leadership focused on fulfilling client programs within defined constraints. Additional experience includes positions as a consumer insights leader at Nielsen, senior market research project manager at GemSeek, and market research project manager at cQuest Research & Consulting, each involving significant project management responsibilities and business development initiatives. Neda's earlier roles also encompass senior research consultant and junior research consultant at GfK, highlighting expertise in market analysis and client relationship management. Neda holds a Master's degree in Marketing and Bachelor's degrees in Sociology from esteemed institutions in Bulgaria.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.